Overall, decreased sphingolipids in FTD-GRN cases, together with increased levels of the sphingolipid catabolic intermediate sphingosine in parietal white matter, support the concept that GRN mutations disrupt brain sphingolipid metabolism. This evidence concerns the gene GRN and frontotemporal dementia.